Monsanto

Cancer Victim Takes Roundup Fight to Supreme Court

A former groundskeeper who developed blood cancer after years of using Roundup is at the center of a Supreme Court case that will determine if Monsanto, its former manufacturer, can be sued for failing to warn about potential cancer risks associated with glyphosate. Despite the manufacturer’s claims that the weedkiller is safe and the Environmental Protection Agency’s stance against mandatory cancer warnings, public health groups and former EPA officials argue that the company should be held accountable for inadequate labeling. The case unfolds amidst a proposed class-action settlement that could resolve many lawsuits and a Trump administration executive order prioritizing domestic glyphosate production, creating a complex legal and political landscape surrounding the herbicide.

Read More

Trump Mandates Cancer-Causing Chemical Production After Promising Healthier Nation

Despite a landmark $289 million verdict against Monsanto for distributing a weedkiller containing the carcinogenic chemical glyphosate, President Trump issued an executive order mandating its production. Invoking the Defense Production Act, Trump claimed a lack of glyphosate herbicides would “critically jeopardize agricultural productivity.” This decision, however, drew sharp criticism from public health advocates and environmental groups who viewed it as a betrayal of promises to protect public health and a move to grant legal immunity to Bayer, the company that acquired Monsanto. The executive order also came after a study supporting glyphosate’s safety was retracted due to ethical concerns regarding Monsanto’s involvement and after Bayer had made a significant donation to the Trump inaugural committee.

Read More

Bayer ordered to pay $2.25 billion after jury links herbicide Roundup to cancer

Bayer, a multinational pharmaceutical and life sciences company, has been ordered to pay a staggering $2.25 billion in damages after a jury linked their herbicide, Roundup, to cancer. As someone with a background in chemical engineering and scientific knowledge, I have some personal insights and opinions on this controversial issue.

Firstly, it is disheartening to see corporations like Bayer create subsidiaries to avoid paying the debts they owe. Johnson and Johnson’s bankruptcy maneuver serves as a reminder of the questionable practices that these companies resort to in order to evade their responsibilities. It is frustrating to witness the power that these corporations wield, seemingly above the law.… Continue reading